Data / Form D filings / Slingshot Biosciences, Inc.
Slingshot Biosciences, Inc.: Form D filings
Slingshot Biosciences, Inc., a company in Emeryville, CA, filed 4 Form D notices with the SEC between 2021 and 2024. The latest, on April 26, 2024, reports $26.2 million sold of a $26.2 million offering to 10 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1250 45TH STREET, SUITE 330, Emeryville, CA, 94608
- Phone
- (510) 770-6806
- Industry
- Other
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1867067
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 26, 2024 | Amendment | $26,227,275 | $26,227,275 | 10 | Jan 24, 2023 | sec.gov | |
| Feb 6, 2023 | New notice | $11,227,334 | $11,227,334 | 8 | Jan 24, 2023 | sec.gov | |
| Jul 23, 2021 | Amendment | $22,879,969 | $22,879,969 | 17 | May 28, 2021 | sec.gov | |
| Jun 14, 2021 | New notice | $14,999,909 | $12,379,974 | $2,619,935 | 16 | May 28, 2021 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Nicolas J Barthelemy | Director | |
| Patrick J Weiss | Director | |
| Corey J Ritter | Director | |
| Andrew J Lee | Director | |
| Ronald J Silberman | Director | |
| Jeffrey Kim | Executive Officer, Director |
Other companies in California that filed recently
- MoFlo Acquisitions, Inc. $587.5 million · Nov 2, 2026
- BC Movie, LLC offering · Nov 2, 2026
- Jana Education San Jose LLC $200,000 · Nov 2, 2026
- Crosscut SPV Frontier LP - Series 2 $23.4 million · Oct 30, 2026
- Series 23-1, a series of StartEngine Private Funds LLC $314,025 · Oct 30, 2026
- Omnissa Holdco LLC offering · Oct 30, 2026
Every Form D from the week of Apr 22, 2024 · All recent filings in California · All recent Other filings
Read from SEC EDGAR. Amount sold is what Slingshot Biosciences, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.